Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 22, 2009, 10:04AM ET - U.S. Markets close in 5 hours and 56 minutes. Dow  0.41% Nasdaq  0.47%

GENMAB (GEN.CO)

At 9:48AM ET: 85.25   1.50 (1.73%)

MORE ON GEN.CO

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Dec 21, 2009 • Genmab's Financial Calendar for 2010 GlobeNewswire (Mon 5:56am) Tue, Dec 8, 2009 • UPDATE - Actelion latest casualty as Roche trims portfolio at Reuters (Tue, Dec 8) Fri, Dec 4, 2009 • UPDATE - Genmab says partner Roche to stop antibody development at Reuters (Fri, Dec 4) • Genmab Announces RG1507 Update GlobeNewswire (Fri, Dec 4) Tue, Nov 10, 2009 • Genmab Announces Results for the Nine Months Period of 2009 GlobeNewswire (Tue, Nov 10) Mon, Nov 9, 2009 • Genmab Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL GlobeNewswire (Mon, Nov 9) Thu, Nov 5, 2009 • Genmab Revises Financial Guidance GlobeNewswire (Thu, Nov 5) • Genmab Reorganizes to Build Sustainable Business GlobeNewswire (Thu, Nov 5) Mon, Oct 26, 2009 • Genmab Achieves Milestone in Arzerra Collaboration GlobeNewswire (Mon, Oct 26) • GSK and Genmab Receive Accelerated Approval for Arzerra GlobeNewswire (Mon, Oct 26) Thu, Oct 8, 2009 • Declaratory Judgment Action Filed by GSK GlobeNewswire (Thu, Oct 8) Wed, Aug 26, 2009 • Genmab Announces Positive Top-Line Results for Arzerra(tm) in Front Line NHL GlobeNewswire (Wed, Aug 26) Tue, Aug 18, 2009 • Genmab Announces 2009 First Half Year Results GlobeNewswire (Tue, Aug 18) Mon, Aug 17, 2009 • Genmab Revises Financial Guidance GlobeNewswire (Mon, Aug 17) • GlaxoSmithKline and Genmab Announce Results From a Study of Arzerra in Rituximab Refractory Follicular NHL GlobeNewswire (Mon, Aug 17) Tue, Aug 11, 2009 • Genmab Announces Preliminary Top-Line Results for Arzerra(TM) in Front Line CLL GlobeNewswire (Tue, Aug 11) Wed, Jul 29, 2009 • GlaxoSmithKline and Genmab Announce Top-Line Results for Ofatumumab in Rheumatoid Arthritis GlobeNewswire (Wed, Jul 29) Fri, Jul 24, 2009 • Recruitment Completed in Arzerra (Ofatumumab) Phase II Study in Relapsed DLBCL GlobeNewswire (Fri, Jul 24) Thu, Jul 16, 2009 • Genmab Announces Lift of Zalutumumab Partial Clinical Hold GlobeNewswire (Thu, Jul 16) Thu, Jul 9, 2009 • Recruitment Completed in Arzerra(tm) (Ofatumumab) Pivotal CLL Study GlobeNewswire (Thu, Jul 9) Older Headlines - Download Recent Headlines View headlines from: Thu, Jul 9, 2009Thu, Jul 2, 2009Thu, Jun 25, 2009Thu, Jun 18, 2009Thu, Jun 11, 2009Thu, Jun 4, 2009Thu, May 28, 2009Thu, May 21, 2009Thu, May 14, 2009Thu, May 7, 2009 Add GEN.CO News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage